Oncology and Hematology - Global Oncology Academy

497-512 of 743

Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
MinuteCE®
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Ignacio Duran, MD; Sandy Srinivas, MD
1.25 program credits
- Ignacio Duran, MD
- Sandy Srinivas, MD
1.25 program credits
MinuteCE®
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
Ignacio Duran, MD; Wenxin Xu, MD
1.25 credits 10 episodes
- Ignacio Duran, MD
- Wenxin Xu, MD
- Sandy Srinivas, MD
1.25 credits 10 episodes
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Project Oncology®
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Constance Lehman, MD, PhD
- Constance Lehman, MD, PhD
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma
MinuteCE®
Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma
Wenxin Xu, MD; Sandy Srinivas, MD
1.25 program credits
- Wenxin Xu, MD
- Sandy Srinivas, MD
1.25 program credits
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
MinuteCE®
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Wenxin Xu, MD; Sandy Srinivas, MD
1.25 program credits
- Wenxin Xu, MD
- Sandy Srinivas, MD
1.25 program credits
Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies
Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies
MinuteCE®
Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies
Ignacio Duran, MD; Wenxin Xu, MD
1.25 program credits
- Ignacio Duran, MD
- Wenxin Xu, MD
1.25 program credits
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
MinuteCE®
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Ritu Salani, MD; Nicoletta Colombo, MD
1.00 program credit
- Ritu Salani, MD
- Nicoletta Colombo, MD
1.00 program credit
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Project Oncology®
Understanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
Rachelle W. Johnson, PhD
- Rachelle W. Johnson, PhD
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Project Oncology®
Treating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Project Oncology®
Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
Heather Greenlee, ND, PhD, MPH
- Heather Greenlee, ND, PhD, MPH
The Potential Link Between COVID-19 and Cancer Regression
The Potential Link Between COVID-19 and Cancer Regression
Clinician's Roundtable
The Potential Link Between COVID-19 and Cancer Regression
Ankit Bharat, MD; Brian P. McDonough, MD, FAAFP
- Ankit Bharat, MD
- Brian P. McDonough, MD, FAAFP
Understanding iMCD Through RNA Sequencing
Understanding iMCD Through RNA Sequencing
Project Oncology®
Understanding iMCD Through RNA Sequencing
Michael Gonzalez, PhD, MSc
- Michael Gonzalez, PhD, MSc
The Future of ITP Care: Exploring New Treatments
The Future of ITP Care: Exploring New Treatments
Project Oncology®
The Future of ITP Care: Exploring New Treatments
Michele Lambert, MD, MSTR
- Michele Lambert, MD, MSTR
Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Project Oncology®
Revolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Heather A. Parsons, MD, MPH
- Heather A. Parsons, MD, MPH
Diagnosing Castleman Disease: Key Considerations
Diagnosing Castleman Disease: Key Considerations
Project Oncology®
Diagnosing Castleman Disease: Key Considerations
Mateo Bustamante
- Mateo Bustamante
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Joshua Brandstadter, MD, PhD, MSc
- Joshua Brandstadter, MD, PhD, MSc

32/11